AZN

AstraZeneca
AZN

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
£161.27B
EV
£181.25B
Shares Outstanding
1.55B
Beta
0.25

Wall Street View

Analyst Rating
BUY
Analyst Target Price
£180.65
P/E 2025E
15.40x
P/Revenue 2025E
3.74x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About AstraZeneca PLC

gainify
AZN

AstraZeneca PLC

AZN

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company’s marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslo...

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Soriot, Pascal

Employees

94,300

IPO Date

1993-05-21

Headquarters

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, Cambridgeshire, CB2 0AA, United Kingdom

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved